Related Experiment Video

Updated: May 14, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

Therapeutic strategies to improve control of hypertension

Pedro Armario1, Bernard Waeber

  • 1Unit of Hypertension and Vascular Risk, Department of Cardiovascular Diseases, Hospital Moisès Broggi, CSI, Univsersity of Barcelona, Spain. parmario@csi.cat

Journal of Hypertension
|February 8, 2013
PubMed

Insights

Blood pressure control remains a challenge, especially for high-risk patients. Fixed-dose triple therapy combining a diuretic, ACE inhibitor/ARB, and CCB offers a promising strategy for difficult-to-control hypertension.

Area of Science:

  • Cardiology
  • Nephrology
  • Endocrinology

Background:

  • Hypertension control rates are low in Europe, particularly in high-risk populations like those with chronic kidney disease, diabetes, or coronary heart disease.
  • Poor blood pressure control is multifactorial, including patient characteristics, lifestyle, comorbidities, and challenges with antihypertensive therapy such as adherence and therapeutic inertia.
  • Monotherapy effectively controls hypertension in only about 30% of patients, necessitating combination therapy, which can further complicate adherence due to polypharmacy.

Purpose of the Study:

  • To highlight the challenges in achieving optimal blood pressure control in a significant patient population.
  • To discuss the role of fixed-combination antihypertensive agents in improving treatment adherence and long-term persistence.
  • To advocate for optimal triple therapy regimens for difficult-to-control hypertensive patients.

Main Methods:

  • This abstract discusses existing knowledge and clinical practice regarding hypertension management.
  • It reviews factors contributing to poor blood pressure control and the limitations of monotherapy.
  • It emphasizes the benefits of fixed-dose combination therapies based on current clinical recommendations.

Main Results:

  • Most hypertensive patients require multiple medications for adequate blood pressure control.
  • Fixed-dose combinations of three antihypertensive agents can simplify treatment regimens.
  • Optimal triple therapy typically includes a diuretic, an ACE inhibitor or ARB, and a calcium channel blocker.

Conclusions:

  • Fixed triple-drug antihypertensive therapy simplifies treatment and can improve adherence and control in challenging cases.
  • A combination of a diuretic, ACE inhibitor/ARB, and CCB is recommended as optimal therapy when well-tolerated.
  • Addressing adherence and therapeutic inertia is crucial for effective long-term hypertension management.

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...